Novel Biologics Versus Conventional Preventive Therapies In Migraine- A Framework for Economic Evaluation
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1997
https://www.valueinhealthjournal.com/article/S1098-3015(17)32331-8/fulltext
Title :
Novel Biologics Versus Conventional Preventive Therapies In Migraine- A Framework for Economic Evaluation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32331-8&doi=10.1016/j.jval.2017.08.1997
First page :
A732
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1823